Healthcare Industry

Showing 1963 articles
Business

Marriott's Stock Soars, But Is It Flying Too Close to the Sun? Analysts Question Valuation After Stellar Run

Marriott International's shares have delivered impressive multi-year gains, but recent analysis suggests the hospitality giant's stock may now be trading at a significant premium. With a DCF model pointing to a 16% overvaluation and a P/E ratio exceeding industry peers, investors are debating whether the price fully reflects future growth or has outpaced fundamentals.

Business

Coty's Deep Discount: A Value Trap or a Beauty Stock Bargain?

Coty Inc.'s shares have tumbled nearly 60% over the past year, trading at a steep discount to industry peers. While a discounted cash flow model suggests significant undervaluation, the prolonged weakness raises questions about the cosmetics giant's turnaround narrative and whether the market is missing a hidden gem.

Business

U.S. Bets on Rare Earths Diversity with $1.6 Billion Rival Backing, MP Materials Navigates New Policy Landscape

The U.S. government's $1.6 billion commitment to USA Rare Earth signals a strategic pivot towards fostering competition in the critical minerals sector, reducing price supports and introducing new volatility. As policy shifts, industry leader MP Materials counters with record production and expanded magnet manufacturing, highlighting the intensifying race to secure a domestic supply chain for EVs and defense.

Business

DaVita Navigates Headwinds as Integrated Kidney Care Turns Profitable Ahead of Schedule

DaVita Inc. reported Q4 2025 results in line with expectations, highlighting a milestone first profitable year for its Integrated Kidney Care unit. While revenue per treatment accelerated, the company continues to face pressure from elevated patient mortality and rising benefit costs. Executives provided 2026 guidance projecting mid-single-digit operating income growth and a sharp rise in EPS, buoyed by share buybacks and the stabilization of prior investment losses.